Day: February 25, 2021

Clinical trials for oncology products have come to literal standstill due to the pandemic and it seems it would be at least 2-5 years before things go back to pre-pandemic levels. Not only that, the pandemic has also severely curtailed the fund-raising for companies and non-profit organizations in the oncology space, some by as much … Read more

Placebo-controlled studies are the global gold standard to evaluate the safety and effectiveness of new drugs. However, can placebo make a new product look better than it actually is by causing adverse effects not otherwise seen or inducing other artifacts that make the active drug look better? An interesting commentary in the Journal of American … Read more